Holen Sie sich die Stockscreener-App
437.33
0.46%
-2.03
Handel nachbörslich:
437.33
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$439.36
Offen:
$436.2
24-Stunden-Volumen:
129.56K
Relative Volume:
0.49
Marktkapitalisierung:
$5.81B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$259.78M
KGV:
23.83
EPS:
18.3497
Netto-Cashflow:
$377.12M
1W Leistung:
-0.62%
1M Leistung:
+3.85%
6M Leistung:
-0.91%
1J Leistung:
-23.22%
1-Tages-Spanne:
$429.10
$440.44
1-Wochen-Bereich:
$429.10
$445.46
52-Wochen-Spanne:
$365.20
$581.20
Chemed Corp Stock (CHE) Company Profile
Firmenname
Chemed Corp
Sektor
Branche
Telefon
(513)762-6690
Adresse
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
437.33 | 5.83B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
392.42 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
176.38 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
195.57 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.58 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.91 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-02 | Hochstufung | Jefferies | Hold → Buy |
| 2025-07-25 | Eingeleitet | Jefferies | Hold |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | Bestätigt | BofA/Merrill | Buy |
| 2018-10-12 | Eingeleitet | BofA/Merrill | Buy |
| 2017-08-28 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | Bestätigt | Oppenheimer | Outperform |
| 2015-10-26 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-27 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | Bestätigt | Oppenheimer | Outperform |
| 2014-09-23 | Bestätigt | Oppenheimer | Outperform |
| 2014-06-10 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2013-09-10 | Bestätigt | Deutsche Bank | Hold |
| 2011-03-04 | Bestätigt | Barclays Capital | Underweight |
| 2011-02-17 | Bestätigt | Oppenheimer | Outperform |
| 2011-02-17 | Bestätigt | RBC Capital Mkts | Sector Perform |
Alle ansehen
Chemed Corp Aktie (CHE) Neueste Nachrichten
Chemed Corp (CHE) Stock Report: Navigating Valuation with a 25.60% ROE and a Modest Upside - DirectorsTalk Interviews
Trading Systems Reacting to (CHE) Volatility - Stock Traders Daily
Chemed Corporation 8-K SEC Filing Summary for May 18, 2026 – Key Entity Information and Voting Results - Minichart
Chemed stockholders elect board, ratify auditor, reject executive pay plan - Investing.com
Shareholders at Chemed (NYSE: CHE) vote down pay plan but back board - Stock Titan
Chemed (NYSE: CHE) director awarded 386 shares of company stock - Stock Titan
Chemed (NYSE: CHE) director granted 386 capital shares in stock award - Stock Titan
CHEMED CORP (CHE) director receives 386-share equity award at $440.77 value - Stock Titan
Chemed (NYSE: CHE) director receives stock award, boosting holdings to 5,925 shares - Stock Titan
Director at Chemed (NYSE: CHE) receives 386-share stock award - Stock Titan
Chemed Corporation Stockholders Elect Directors, Ratify Accountants, and Declare Quarterly Dividend - Quiver Quantitative
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend - GlobeNewswire
220 consecutive dividends from the company behind VITAS and Roto-Rooter - Stock Titan
Chemed Corp (CHE) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential with a 2.75% Upside - DirectorsTalk Interviews
Chemed Conference Webcast Puts Dual Businesses And Valuation In Focus - Yahoo Finance
Chemed Corp stock (US1638321034): hospice and plumbing specialist draws investor focus after latest - AD HOC NEWS
Chemed Corp stock (US1638321034): Presentation at RBC Healthcare Conference - AD HOC NEWS
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference - Caledonian Record
Chemed Corp (CHE) Stock Analysis: Navigating the Healthcare Sector with a 5.24% Potential Upside - DirectorsTalk Interviews
C WorldWide Group Holding A S Invests $2.19 Million in Chemed Corporation $CHE - MarketBeat
How Chemed Corp (CHE) Affects Rotational Strategy Timing - Stock Traders Daily
CHE SEC FilingsChemed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[144] CHEMED CORP SEC Filing - Stock Titan
Chemed director Patrick P. Grace sells $25,546 in stock By Investing.com - Investing.com Australia
Chemed director Patrick P. Grace sells $25,546 in stock - Investing.com
Chemed Corp (CHE) director sells 60 shares at $425.78 - Stock Titan
Chemed Corp stock (US1638321034): Home health and hospice growth continues to drive earnings - AD HOC NEWS
CHE Stock Price, Quote & Chart | CHEMED CORP (NYSE:CHE) - ChartMill
Chemed Corporation $CHE Shares Acquired by UBS Group AG - MarketBeat
Sadness This Mother's Day? VITAS® Healthcare Launches Free, Nationwide Mother's Day Grief Helpline - Quantisnow
The company behind VITAS and Roto-Rooter presents in Las Vegas May 12 - Stock Titan
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026 - GlobeNewswire
Van Berkom & Associates Inc. Acquires 4,056 Shares of Chemed Corporation $CHE - MarketBeat
Chemed Corporation $CHE Shares Acquired by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Chemed to present at Bank of America Health Care Conference on May 12, 2026 - Pluang
Chemed CEO Kevin McNamara sells $842,260 in Che stock - Investing.com India
Chemed CEO Kevin McNamara sells $842,260 in Che stock By Investing.com - Investing.com Australia
Chemed (CHE) CEO Kevin McNamara sells 2,000 shares at $421.13 average - Stock Titan
Chemed Corp (CHE) Stock Analysis: Navigating Healthcare Growth with a 5.77% Upside Potential - DirectorsTalk Interviews
Chemed (NYSE:CHE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Chemed Corporation (NYSE: CHE) affiliate files Form 144 to sell 1,000 shares - Stock Titan
Kevin McNamara reports Common stock sales (CHE) on Form 144 - Stock Titan
Water Management Takes Centre Stage at Data Centre LIVE - GlobeNewswire Inc.
Vanguard Capital Management (CHE) reports 744,055 shares, 5.40% stake - Stock Titan
Vanguard holds 817,550 Chemed shares (CHE) — 5.93% stake - Stock Titan
(CHE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Chemed (NYSE:CHE) Raised to Hold at Zacks Research - MarketBeat
CHE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Chemed 10-Q: Revenue $657.5M, EPS $4.84 - TradingView
Chemed (NYSE: CHE) posts Q1 2026 revenue growth with lower profit - Stock Titan
Chemed Q1 Earnings Call Highlights - MarketBeat
Finanzdaten der Chemed Corp-Aktie (CHE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.97%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):